Holds 2 active US DMFs and 8 valid CEPs for mometasone, filing since 2013. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 34 markets.
EDQM certificate database
FDA, List of Drug Master Files
Holds 2 active US DMFs and 8 valid CEPs for mometasone, filing since 2013. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 34 markets.
Holds one active US DMF for mometasone, filing since 2008. Its 2015 FDA inspection closed as NAI.
Holds 4 active US DMFs for mometasone, filing since 2008. Its 2026 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Holds 2 active US DMFs for mometasone, filing since 2007. Its 2022 FDA inspection closed as VAI.
Holds 6 active US DMFs for mometasone, filing since 2016. Its 2019 FDA inspection closed as VAI.
Holds 2 valid CEPs for mometasone, filing since 2022. Its GMP is recognised in 2 markets.
The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.
Open the full list with a free accountThis page filters the worldwide Mometasone manufacturer list to companies based in India. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.
Start for free